Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 18Gynecologic 5Thoracic 3Sarcoma 1Other solid neoplasm 1NET 1Endocrine 1Breast 1

Conditions

Neuroendocrine Tumors 1

Interventions

lutetium Lu 177 dotatate 1apatinib 1Watchful Waiting 1Surveys and Questionnaires 1Radiomics 1Engineering 1Endoscopic Mucosal Resection 1Cisplatin 1Chemotherapy, Adjuvant 1Carboplatin 1Biological Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × apatinib × NET × Clear all
NCT06764368 2025-01-08

Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors

Beijing Chest Hospital

Phase 2 Not yet recruiting
39 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡